Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Sale: Director at $MELI Sells 845 Shares

Automated

Henrique Vasoncelos Dubugras, a director at $MELI, sold 845 shares of the company on 12-12-2025 for an estimated $1,713,778. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares of this class of stock. Following this trade, they now own 0 shares of this class of $MELI stock.

$MELI Insider Trading Activity

MELI Insider Trades

$MELI insiders have traded $MELI stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $MELI stock by insiders over the last 6 months:

  • HENRIQUE VASONCELOS DUBUGRAS sold 845 shares for an estimated $1,713,778
  • STELLEO TOLDA sold 246 shares for an estimated $503,778
  • EMILIANO CALEMZUK sold 45 shares for an estimated $91,231

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$MELI Hedge Fund Activity

We have seen 742 institutional investors add shares of $MELI stock to their portfolio, and 673 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$MELI Revenue

MELI Quarterly Revenue

$MELI had revenues of $7.4B in Q3 2025. This is an increase of 39.48% from the same period in the prior year.

You can track MELI financials on Quiver Quantitative's MELI stock page.

$MELI Congressional Stock Trading

Members of Congress have traded $MELI stock 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $MELI stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$MELI Analyst Ratings

Wall Street analysts have issued reports on $MELI in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • BTIG issued a "Buy" rating on 12/04/2025
  • UBS issued a "Buy" rating on 11/24/2025
  • Morgan Stanley issued a "Overweight" rating on 11/03/2025
  • Barclays issued a "Overweight" rating on 10/30/2025
  • Cantor Fitzgerald issued a "Overweight" rating on 10/30/2025
  • Benchmark issued a "Buy" rating on 10/30/2025
  • Susquehanna issued a "Positive" rating on 10/13/2025

To track analyst ratings and price targets for $MELI, check out Quiver Quantitative's $MELI forecast page.

$MELI Price Targets

Multiple analysts have issued price targets for $MELI recently. We have seen 13 analysts offer price targets for $MELI in the last 6 months, with a median target of $2780.0.

Here are some recent targets:

  • Marvin Fong from BTIG set a target price of $2750.0 on 12/04/2025
  • Kaio Prato from UBS set a target price of $2900.0 on 11/24/2025
  • Marcelo Santos from JP Morgan set a target price of $2650.0 on 11/03/2025
  • Andrew Ruben from Morgan Stanley set a target price of $2950.0 on 11/03/2025
  • Deepak Mathivanan from Cantor Fitzgerald set a target price of $2750.0 on 10/30/2025
  • Fawne Jiang from Benchmark set a target price of $2780.0 on 10/30/2025
  • Trevor Young from Barclays set a target price of $2900.0 on 10/30/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles